HemaCare Co. (OTCMKTS:HEMA – Get Free Report) was up 0.6% during trading on Tuesday . The stock traded as high as $25.31 and last traded at $25.31. Approximately 5,400 shares were traded during mid-day trading, a decline of 86% from the average daily volume of 39,950 shares. The stock had previously closed at $25.16.
HemaCare Stock Up 0.6 %
The company has a 50-day moving average price of $25.31 and a two-hundred day moving average price of $25.31.
HemaCare Company Profile
HemaCare Corporation provides human-derived primary blood cells and tissues for biomedical research, and supporting cell therapy clinical trials and commercialization with apheresis collections in the United States. The company specializes in the customized collection, isolation, and testing of primary human blood cells and other biological products for research protocols and cellular therapy.
Featured Stories
- Five stocks we like better than HemaCare
- What Does Downgrade Mean in Investing?
- Gilead’s Stock Surge: What’s Fueling the Momentum?
- What to Know About Investing in Penny Stocks
- Breakout Alert: Qualcomm Just Hit The Rally Button
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Mercado Libre Shares Go on Sale: Is Now the Time to Buy?
Receive News & Ratings for HemaCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HemaCare and related companies with MarketBeat.com's FREE daily email newsletter.
